(A) Points are estimated mean values (±SE), of outcome plotted at t = -5 years (before CFLD diagnosis), t = 0 years (time of CFLD diagnosis), and t = 5 years (after CFLD diagnosis) for a patient age 13.3 years (average age at CFLD diagnosis). CF-specific FEV1 percentile (solid line) and FEV1% predicted (dashed line) are shown in 118 CFLD subjects with lung function values before and after CFLD diagnosis. (B) Averaged data at t = 0 and t = 5 years (±SE), including an additional 61 patients with post-CFLD diagnosis lung function values (total subjects, n = 179).</p
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The combination of lumacaftor and ivacaftor (LUM/IVA) is a recently approved CFTR modula...
<p>Mean regional normalized T1 (nT1) values as a function of FEV<sub>1</sub>% predicted for all ten ...
BackgroundForced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in c...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
<p>Kaplan-Meier plots relative to age at first acute episode with FEV1 <60% of predicted value. (A) ...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
<p>Representative absolute (left column) and normalized (right column) T1 relaxation time maps from ...
<p>a) forced expiratory volume in 1 second (FEV<sub>1</sub>); b) total lung capacity (TLC); c) funct...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The combination of lumacaftor and ivacaftor (LUM/IVA) is a recently approved CFTR modula...
<p>Mean regional normalized T1 (nT1) values as a function of FEV<sub>1</sub>% predicted for all ten ...
BackgroundForced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in c...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
<p>Kaplan-Meier plots relative to age at first acute episode with FEV1 <60% of predicted value. (A) ...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
<p>Representative absolute (left column) and normalized (right column) T1 relaxation time maps from ...
<p>a) forced expiratory volume in 1 second (FEV<sub>1</sub>); b) total lung capacity (TLC); c) funct...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies...
Background: The combination of lumacaftor and ivacaftor (LUM/IVA) is a recently approved CFTR modula...